These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Transportation capacity for patients with highly infectious diseases in Europe: a survey in 16 nations. Schilling S; Maltezou HC; Fusco FM; De Iaco G; Brodt HR; Bannister B; Brouqui P; Carson G; Puro V; Gottschalk R; Ippolito G; Clin Microbiol Infect; 2019 Apr; 21S():e1-e5. PubMed ID: 24750421 [TBL] [Abstract][Full Text] [Related]
10. High-Level Isolation Unit Infection Control Procedures. Herstein JJ; Biddinger PD; Gibbs SG; Le AB; Jelden KC; Hewlett AL; Lowe JJ Health Secur; 2017; 15(5):519-526. PubMed ID: 29058966 [TBL] [Abstract][Full Text] [Related]
11. The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats. Nisii C; Castilletti C; Di Caro A; Capobianchi MR; Brown D; Lloyd G; Gunther S; Lundkvist A; Pletschette M; Ippolito G; Clin Microbiol Infect; 2009 Aug; 15(8):720-6. PubMed ID: 19754729 [TBL] [Abstract][Full Text] [Related]
13. Biosafety Requirements for Autopsies of Patients with COVID-19: Example of a BSL-3 Autopsy Facility Designed for Highly Pathogenic Agents. Loibner M; Langner C; Regitnig P; Gorkiewicz G; Zatloukal K Pathobiology; 2021; 88(1):37-45. PubMed ID: 33296902 [TBL] [Abstract][Full Text] [Related]
14. Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research. Nisii C; Castilletti C; Raoul H; Hewson R; Brown D; Gopal R; Eickmann M; Gunther S; Mirazimi A; Koivula T; Feldmann H; Di Caro A; Capobianchi MR; Ippolito G PLoS Pathog; 2013 Jan; 9(1):e1003105. PubMed ID: 23349630 [No Abstract] [Full Text] [Related]
15. Biosafety and biosecurity measures: management of biosafety level 3 facilities. Zaki AN Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002 [TBL] [Abstract][Full Text] [Related]
16. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017. Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R; Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748 [TBL] [Abstract][Full Text] [Related]
17. U.S. Medical Examiner/Coroner capability to handle highly infectious decedents. Le AB; Brooks EG; McNulty LA; Gill JR; Herstein JJ; Rios J; Patlovich SJ; Jelden KC; Schmid KK; Lowe JJ; Gibbs SG Forensic Sci Med Pathol; 2019 Mar; 15(1):31-40. PubMed ID: 30402743 [TBL] [Abstract][Full Text] [Related]
18. Containment Care Units for Managing Patients With Highly Hazardous Infectious Diseases: A Concept Whose Time Has Come. Kortepeter MG; Kwon EH; Hewlett AL; Smith PW; Cieslak TJ J Infect Dis; 2016 Oct; 214(suppl 3):S137-S141. PubMed ID: 27651413 [TBL] [Abstract][Full Text] [Related]
19. Biosafety considerations for autopsy. Nolte KB; Taylor DG; Richmond JY Am J Forensic Med Pathol; 2002 Jun; 23(2):107-22. PubMed ID: 12040252 [TBL] [Abstract][Full Text] [Related]
20. Facing highly infectious diseases: new trends and current concepts. Brouqui P Clin Microbiol Infect; 2009 Aug; 15(8):700-5. PubMed ID: 19486075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]